BRONCHOPULMONARY DYSPLASIA: FROM NORTHWAY TO OUR DAYS


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

The review gives information on the pathomorphism of bronchopulmonary dysplasia originally described as iatrogenia in extremely premature babies who have been on mechanical ventilation. It provides a comparative characterization of the classical and new forms of the disease. Therapy with an exogenous surfactant (poractant alpha) is shown to affect the frequency and course of bronchopulmonary dysplasia and late outcomes in babies and infants are described.

全文:

受限制的访问

作者简介

D. OVSYANNIKOV

Russian Peoples' Friendship University

Email: mdovsyannikov@yahoo.com

参考

  1. Вауэр Р.Р. Сурфактант в неонатологии. Профилактика и лечение респираторного дистресс-синдрома новорожденных. — М.: Медицинская литература, 2011.
  2. Давыдова И.В. Формирование, течение и исходы бронхолегочной дисплазии у детей: Автореф. дис.. д-ра мед. наук. — М., 2010.
  3. Лесфилд С. Бронхолегочная дисплазия // Р.Э. Берман, Клигман Р.М., Джонсон Х.Б. Педиатрия по Нельсону: Пер. с англ. Т. 4. — М.: Рид Элсивер, 2009. — С. 589—591.
  4. Овсянников Д.Ю. Бронхолегочная дисплазия у детей первых трех лет жизни: Автореф. дис. д-ра мед. наук. — М., 2010.
  5. Овсянников Д.Ю. Бронхолегочная дисплазия: естественное развитие, исходы и контроль // Педиатрия. — 2011. — Т. 90, № 1. — С. 141—150.
  6. Abman S.H., Davis J.M. Bronchopulmonary dysplasia // Kendig’s disorders of the respiratory tract in children // Eds. V. Chernick et al. — Philadelphia: Elsevier, 2006. — P. 342—358.
  7. American Academy of pediatrics. Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants // Pediatrics. — 2002. — Vol. 109, № 2. — P. 330—338.
  8. Bancalari E., Claure N., Sosenko I.R.S. Bronchopulmonary dysplasia: changes in pathogenesis, epidemiology and definition // Semin. Neonatol. — 2003. — Vol. 8. — P. 63—71.
  9. Bevilacqua G., Halliday H.L., Parmigiani S. et al. Randomized multicenter trial of treatment with porcine natural surfactant for moderately severe neonatal respiratory distress syndrome // J. Perinat. Med. — 1993. — Vol. 21. — P. 329—340.
  10. Collaborative European Multicenter Study Groap. Surfactant replacement therapy for severe neonatal respiratory distress syndrome: An international randomized clinical trial // Pediatrics. — 1988. — Vol. 82. — P. 83—91.
  11. Egberts J., Brand R., Walti H. et al. Mortality, severe respiratory distress syndrome, and chronic lung disease of the newborn are redused more after prophylactic than after administration of the surfactant Curosurf // Pediatrics. — 1997. — Vol. 100, № 1. — P. 123—129.
  12. Gonzalez A., Sosenko I.R.S., Chandar J. et al. Influence of infection on patent ductus arteriosus and chronic lung disease in premature infants weighing 1000 grams and less // J. Pediatr. — 1996. — Vol. 128. — P. 470—478.
  13. Greenough A., Kotecha S., Vrijlandt E. Bronchopulmonary dysplasia: current models and concepts // Eur. Respir. Monogr. — 2006. — Vol. 37. — P. 217—233.
  14. Hussain N., Siddiqui P., Stocker J. Pathology of arrested acinar development in postsurfactant bronchopulmonary dysplasia // Hum. Pathol. — 1998. — Vol. 29. — P. 710—721.
  15. Kaam A.H. van de, De Jaegere A.P., Borensztajn D. et al. Surfactant replacement therapy in preterm infants: A European survey // Neonatology. — 2011. — Vol. 100. — P. 71—77.
  16. Markestad T., Fitzhardinge P.M. Growth and development in children recovering from bronchopulmonary dysplasia // Pediatrics. — 1981. — Vol. 98. — P. 597—602.
  17. Mayes L., Perkett E., Stahleman M.T. Severe bronchopulmonary dysplasia: a retrospective review // Acta Paediatr. Scand. — 1983. — Vol. 72, № 1—2. — P. 220—229.
  18. Northway W.H.Jr., Rosan R.C., Porter D.Y. Pulmonary disease following respiratory therapy of hyaline membrane discease // N. Engl. J. Med. — 1967. — Vol. 276. — P. 357—368.
  19. Oppermann H.C., Williie L., Beyl Obladen N. Bronchopulmonary dysplasia in premature infants: a radiological and pathological correlation // Pediatr. Radiol. — 1974. — Vol. 5. — P. 137—141.
  20. Palta M., Sadek M., Barnet J. H. et al. Evaluation of criteria for chronic lung disease in surviving very infants. Newborn Lung Project // J. Pediatr. — 1998. — Vol. 132. — P. 57—62.
  21. Rojas M.A., Gonzalez A., Bancalari E. et al. Changing trends in the epidemiology and pathogenesis of neonatal chronic lung disease // J. Pediatr. — 1995. — Vol. 126. — P. 605—610.
  22. Schmidt B. Caffeine therapy for apnea of prematurity // N. Engl. J. Med. — 2006. — Vol. 354. — P. 2112—2121.
  23. Sweet D., Carnielli V., Greisen G. et al. Europian consensus guidelines on the management of neonatal respiratory distress syndrome in preterm infants — 2010 update // Neonatology. — 2010. — Vol. 97. — P. 402—417.
  24. Tommiska V., Heinonen K., Kero P. et al. A national two year follow up study of extremely low birthweight infants born in 1996- 1997 // Arch. Dis. Child. Fetal Neonatal Ed. — 2003. — Vol. 88. — Р. 29.
  25. Yu V.Y.H., Orgill A.A., Lim S.B. et al. Growth and development of very low birthweight infants recovering from bronchopulmonary dysplasia // Arch. Dis. Child. — 1983. — Vol. 58. — P. 791—794.
  26. Walsh M.C., Yao Q., Horbar J.D. et al. Changes in the use of postnatal steroids for bronchopulmonary dysplasia in 3 large neonatal networks // Pediatrics. — 2006. — Vol. 118. — P. 1328—1335.

补充文件

附件文件
动作
1. JATS XML
下载

版权所有 © ООО «Бионика Медиа», 2011
##common.cookie##